Timing clarification: Rollins is scheduled to release Q2 results after the market closes today, Wednesday, July 22, 2026. The earnings call is tomorrow, Thursday, July 23, at 8:30 a.m. ET. (rollins.com)
The central question is not whether Rollins can produce another quarter of high-single-digit or low-double-digit revenue growth. The more important issue is whether the strong March demand exit rate translates into peak-season organic growth and better operating leverage.
Investors should focus on three items:
A merely in-line revenue result may not be enough if margins remain under pressure or management sounds less confident about the second half.
External estimates currently cluster around the following:
| Q2 2026 metric | Consensus | Q2 2025 | Implied change |
|---|---|---|---|
| Revenue | $1.09–$1.10 billion | $999.5 million | Approximately 9%–10% |
| Adjusted EPS | $0.34 | $0.30 | Approximately 13% |
| Adjusted EBITDA | Approximately $248 million | $231.2 million | Approximately 7% |
| Implied adjusted EBITDA margin | Approximately 22.6% | 23.1% | Approximately 50 bps lower |
Consensus data are drawn from third-party estimate aggregators and may vary slightly by provider. (benzinga.com)
The comparison is reasonably demanding on the top line but still appears cautious on profitability. Rollins generated $999.5 million of revenue, $231 million of adjusted EBITDA, and $0.30 of adjusted EPS in Q2 2025. (rollins.com)
Q1 revenue increased 10.2%, including 6.6% organic growth and 3.6 percentage points from acquisitions. More encouragingly, organic growth exceeded 8% in March after unfavorable January weather. However, at the May 14 Investor Day, management said organic growth through the first four months of 2026 was still only around 6.5%–7%. (rollins.com)
That creates a clear test for Q2:
Residential organic growth was only 4.2% in Q1, but management said it exceeded 7% in March. Because residential demand is more seasonal and weather-sensitive than commercial demand, this segment should provide the clearest evidence of whether peak pest season developed as expected.
Watch for commentary on:
Commercial organic revenue increased 7.7% in Q1. Rollins has invested heavily in dedicated commercial sales resources, branch specialization, and high-value verticals such as food processing, logistics, healthcare, and hospitality. Management has indicated that commercial sales investments can require six to twelve months to reach fuller productivity, making Q2 an important progress check. (d1io3yog0oux5.cloudfront.net)
Termite and ancillary organic growth was nearly 10% in Q1. At Investor Day, Rollins said ancillary services represent about 10% of revenue but reach less than 5% of the customer base, leaving substantial room for cross-selling across non-Orkin brands. (d1io3yog0oux5.cloudfront.net)
This category is important because it can support both revenue growth and customer retention. Continued double-digit growth would strengthen the case that Rollins can sustain organic growth above the broader pest-control market.
Q1 adjusted EBITDA margin declined 110 basis points to 19.8%. The pressures included:
Management expected peak-season volume and improved fleet comparisons to produce better profitability in Q2 and Q3. (rollins.com)
At Investor Day, management maintained a 30%–35% medium-term incremental-margin objective, although former CFO Ken Krause said 25%–30% for 2026 was a more realistic near-term range. Rollins also identified potential gross-margin benefits from better employee retention, procurement, fleet efficiency, and CPI-plus pricing. (d1io3yog0oux5.cloudfront.net)
A favorable report would show:
Consensus appears to allow for another roughly 50-basis-point decline in adjusted EBITDA margin. Therefore, even a roughly flat year-over-year margin could be viewed positively, particularly if organic growth is at least 7%.
Claims expense has been volatile because older auto and liability claims can take several years to mature. Management has reported better collision and injury frequency, but those operational improvements may take time to appear in reported claims expense. Investors should distinguish between:
Another material claims headwind would weaken confidence in the 2026 incremental-margin objective.
Rollins expects acquisitions to contribute 2%–3% of 2026 revenue growth. Q2 includes the April 1 acquisition of Romex Pest Control, acquired for $90 million plus up to $10 million of contingent consideration. Romex has more than 200 employees and provides Rollins with entry points into additional U.S. markets. (rollins.com)
Investors should look for:
A higher acquisition contribution is not automatically bullish if it is accompanied by weaker organic growth or margin dilution.
This will be William Harkins’ first earnings cycle as CFO after succeeding Ken Krause on June 15. Harkins was previously Rollins’ chief accounting officer. The company stated that Krause left to pursue another opportunity, that the departure did not involve a disagreement, and that he will provide transition support through September 30. (rollins.com)
The market will be listening for continuity in:
A clear, detailed presentation from Harkins would help reduce transition uncertainty. Any retreat from the targets presented at the May Investor Day would be a material negative.
Q1 free cash flow declined because of approximately $40 million in tax-payment timing and $9 million associated with the shift to semiannual interest payments. The underlying business still converted more than 100% of net income into free cash flow. (rollins.com)
Q2 cash flow will be worth monitoring for evidence that these timing effects are beginning to normalize. The broader investment case depends on Rollins continuing to convert earnings into cash at greater than 100%, providing funding for acquisitions, dividends, and occasional repurchases.
ROL was recently around $43.86 per share, with a trailing P/E of approximately 40 times. Despite the stock’s substantial pullback from earlier-2026 levels, the valuation continues to embed confidence in durable organic growth and eventual margin expansion.
That means the likely market reaction will depend less on a one-cent EPS beat and more on whether management demonstrates that:
This would support the argument that Q1’s weak profitability was seasonal and temporary.
This would be an acceptable result, although the stock reaction could depend heavily on margin guidance.
The key hurdle is peak-season operating leverage, not simply revenue growth. Consensus already expects roughly 9%–10% total revenue growth and low-teens adjusted EPS growth. For the report to meaningfully improve sentiment, Rollins likely needs to deliver organic growth at or above 7%, show clear sequential margin recovery, and reaffirm the financial algorithm under its new CFO.
The most useful single combination to watch is:
Organic revenue growth plus adjusted incremental EBITDA margin.
A healthy organic result without margin recovery would suggest Rollins is still buying growth through elevated staffing and selling expense. Margin improvement without solid organic growth would be less durable. A report showing both would provide the strongest evidence that the long-term compounder thesis remains on track.